Related Experiment Video
Updated: May 31, 2026
08:03
A Tandem Liquid Chromatography–Mass Spectrometry-based Approach for Metabolite Analysis of Staphylococcus aureus
Published on: March 28, 2017
Immune proteomics of Staphylococcus aureus.
Barbara M Bröker1, Alex van Belkum
1Department of Immunology, University of Greifswald, Germany. broeker@uni-greifswald.de
Proteomics
|June 29, 2011
Summary
Immune proteomics reveals Staphylococcus aureus host-pathogen interactions. Studies show diverse adaptive immune responses and personalized antibody profiles in S. aureus carriers and non-carriers.
Area of Science:
- Microbiology
- Immunology
- Proteomics
Background:
- The adaptive immune response to microbial encounters is complex.
- Staphylococcus aureus interactions with hosts present a model for studying host-pathogen dynamics.
- Understanding these interactions is crucial for developing vaccines and therapeutics.
Purpose of the Study:
- To illustrate the application of immune proteomics in detailing host-pathogen interactions.
- To explore the diversity of adaptive immune responses to Staphylococcus aureus.
- To identify general rules governing immune responses to S. aureus colonization and infection.
Main Methods:
- Utilizing high-resolution immune proteome studies.
- Analyzing adaptive immune responses in Staphylococcus aureus carriers and non-carriers.
- Investigating antibody profiles in relation to S. aureus exposure history.
Main Results:
- Immune proteomics provides detailed insights into host-pathogen interactions.
- Both S. aureus carriers and non-carriers exhibit specific antibody responses.
- Individual baseline antibody profiles reflect personal S. aureus exposure history.
Conclusions:
- Immune proteomics is a powerful tool for studying adaptive immunity.
- Host immune responses to S. aureus are diverse yet follow emerging general patterns.
- Personalized antibody profiles are key to understanding individual immune status against S. aureus.
Related Concept Videos
01:29Staphylococcal Skin Infections
Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
01:33Proteomics
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...